Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024
Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020
Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice
Front Neurol 7:1-16, Nouh, A.,et al, 2016
Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016
Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention
Stroke 43:422-431, Kitsios,G.D.,et al, 2012
Neurological Complications of Sclerotherapy for Varicose Veins
J Vasc Surg 55:243-251, Sarvananthan, T.,et al, 2012
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011
Etiologic investigation of ischemic stroke in young adults
Neurol 76:1983-1988, Larrue, V.,et al, 2011
Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Syndrome)
UpToDate, Feb, Shovlin, C., 2011
Recurrent Cerebral Ischemia in Medically Treated Patent Foramen Ovale: A Meta-Analysis
Neurol 73:89-97,84, Almekhlafi,M.A.,et al, 2009
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008
Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke
JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 37:577-617, Sacco,R.L.,et al, 2006
Closure of Patent Foramen Ovale After Cryptogenic Stroke
Lancet 368:350-352, Wrle,J., 2006
Patent Foramen Ovale Closure Devices
JAMA 294:366-369, Maisel,W.H.&Laskey,W.K., 2005
Assessment: Transcranial Doppler Ultrasonography
Neurol 62:1468-1481, Sloan,M.A.,et al, 2004
Stroke Prevention
Neurol Clin 18:321-341, Wein,T.H. &Bornstein,N.M., 2000
Preventing Stroke Recurrence in Patients with Patent Foramen Ovale: Antithrombotic Therapy, Foramen Closure, or Therapeutic Abstention? A Decision Analytic Perspective
Am Heart J 135:532-541, Nendaz,M.R.,et al, 1998
Causes and Mechanisms of Cerebellar Infarction in Young Patients
Stroke 28:2400-2404, Barinagarrementeria,F.,et al, 1997
Brain Embolism, Revisited
Neurol 43:1281-1287, Caplan,L., 1993
Cardiogenic Brain Embolism
The Second Report of the Cerebral Embolism Task Force, Cerebral Embolism Task Force, Arch Neurol 46:, 2743,1989., 1989
Clinical Spectrum of Hereditary Hemorrhagic Telangiectasia (Osler-Wever-Rendu Disease)
Am J Med 82:989-997, Perry,W.H., 1987
Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia: A Series of 126 Patients
Medicine 86:1-7, Cottin,V.,et al, 2007
Cerebrovascular Manifestations in 321 Cases of Hereditary Hemorrhagic Telangiectasia
Stroke 32:877-882, Maher,C.O.,et al, 2001
Hereditary Hemorrhagic Telangiectasia
NEJM 333:918-924, Guttmacher,A.E.,et al, 1995
Cardiac Magnetic Resonance Imaging: A New Tool to Identify Cardioaortic Sources in Ischaemic Stroke
JNNP 88:31-37, Yaghi, S.,et al, 2017
Visuospatial deficits in posterior cortical atrophy: structural and functional correlates
JNNP 83:860-863,855, Andrade, K.,et al, 2012
A New Landscape for Stroke Prevention in Atrial Fibrillation
Stroke 42:3316-3322, Banerjee, A.,et al, 2011
Atrial Fibrillation and Stroke
Stroke 32:803-808, Hart,R.G. &Halperin,J.L., 2001
Cerebral Injury After Cardiac Surgery,Identification of a Group of Extraordinary Risk
Stroke 30:514-522, Wolman,R.L.,et al, 1999
Pain After Thalamic Stroke:Right Diencephalic Predominance and Clinical Features in 180 Patients
Neurol 48:1196-1199, Nasreddine,Z.S.&Saver,J.L., 1997
Safety and Magnetic Resonance Imaging
BMJ 308:1181-1182, Mosely,I., 1994
Unilateral Amnesic Stroke:Six New Cases and a Review of the Literature
Stroke 24:1033-1042, Ott,B.R.&Saver,J.L., 1993
Gerstmann's Syndrome
Arch Neurol 49:445-447, Benton,A.L., 1992
Anosognosia in Patients with Cerebrovascular Lesions, A Study of Causative Factors
Stroke 23:1446-1453, Starkstein,S.E.,et al, 1992
Stroke in Young Adults
Stroke 21:382-386, Bevan,H.,et al, 1990
Echocardiography
NEJM 323:165-172, Popp,R.L., 1990
Cerebrovascular Disease in AIDS:A Case-Control Study
AIDS 4:239-244, Berger,J.R.,et al, 1990
Clinical & Neuropath Findings in SLE:Role of Vasculitis, Heart Emboli, & Thrombotic Thrombocytopenia Purpura
Ann Neurol 23:380-384, Devinsky,O.,et al, 1988
Cardiogenic Brain Embolism
Cerebral Embolism Task Force, Arch Neurol 43:71-841986., , 1986
Cerebral Lateralization, Biological Mechanisms, Associations, & Pathology:I
Arch Neurol 42:428-459, 4271985., Geschwind,N.&Galaburda,A.M., 1985
Cerebral Lateralization, Biological Mechanisms, Associations, & Pathology:II
Arch Neurol 42:521-552, Geschwind,N.&Galaburda,A.M., 1985
Cerebral Lateralizaion, Biological Mechanisms, Associations, & Pathology:III
Arch Neurol 42:634-654, Geschwind,N.&Galaburda,A.M., 1985
Extrapulmonary Manifestations of Sarcoidosis
Rheum Dis Clin North Am 39:277-297, Rao,D.A. & Dellaripa,P.F., 2023
Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
Current and Emerging Issues in Wilsons Disease
NEJM 389:922-938, Roberts,E.A. & Schilsky, M.L., 2023
Thyrotoxic Periodic Paralysis
UptoDate Jan, Gutmann, L. & Conwit, R., 2022
Myotonic Dystrophy: Etiology, Clinical Features, and Diagnosis
UptoDate 2022 Jan, Darras, B.T., 2022
Spontaneous Subarachnoid Haemorrhage
Lancet 400:846-862, Claassen, J. & Park, S., 2022